Risk for multidrug-resistant tuberculosis in patients treated with anti-tumor necrosis factor agents.
Frontiers in medicine（2023）
摘要
Treatment with an anti-TNF agent could be a driver of MDR-TB in patients with pulmonary TB.
更多查看译文
关键词
anti-TNF agents,infections,multidrug-resistant tuberculosis,pulmonary TB,risk factor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要